Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia. - Wikidata - awgldk - TriplyDB

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

http://www.wikidata.org/entity/Q35234869

about

So you think you can jump? A novel long jump assessment to detect deficits in stroked mice.Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy.2014 Thomas Willis Award Lecture: sex, stroke, and innovation Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity.A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke.Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.Partial MHC Constructs Treat Thromboembolic Ischemic Stroke Characterized by Early Immune Expansion Sex differences in the immune response to experimental stroke: Implications for translational research.A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.Partial MHC class II constructs as novel immunomodulatory therapy for stroke.Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures?The splenic response to stroke: from rodents to stroke subjects.

P2860

Q30679421-E6A171FB-C64F-4712-BA77-EA9B00841B25 Q34001070-CFDE6289-57EF-4730-B0C7-CCAEF5163F0E Q34242088-A62DA33D-F039-4D28-8855-E7B015D77A3C Q34577247-30CE8665-0945-4D9A-AE22-43DEC37C10BB Q34982895-DF1F2C14-90B2-4BCE-8673-C105D64301B4 Q35722702-D7CABDD4-86C6-4D18-94F9-032A08E7406A Q36408695-EBECBAEA-08D3-45FD-9CD2-3AF391706B4B Q36579398-754F6182-C0CB-4226-86B3-18DBAA352873 Q36790648-944A5DDA-767E-4F2D-9632-07A921DDF8BD Q37432327-4321F0C9-0792-43EE-A839-85F3A35B7AD6 Q37684577-1691D8A2-44FE-4BEB-9898-CD4AD58EF5EA Q38791052-F6341C9D-F34A-47D2-93EF-172D960AD50E Q38988985-FB5A87AC-3E0F-4916-B484-8997C649DE67 Q52370950-792ED771-D26B-438A-8B41-46B7291C4811 Q55518592-AC6D92B4-DFD0-4F4D-9FA5-63F0919394B1

P2860

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

http://www.wikidata.org/entity/Q35234869

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

@ast

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

@en

type

label

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

@ast

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

@en

prefLabel

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

@ast

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

@en

P1433

Q35234869-3CC66030-B5A3-4A63-80B7-5B89E9192D81

P1476

Q35234869-6C4D084E-7B5C-45ED-9C7C-0B70E1B16250

P2093

Q35234869-20B09E02-B966-4245-937C-A6752FF84B74

Q35234869-2704A73A-A743-48E8-B4C3-B72B2DD20694

Q35234869-5FCCDCCC-5A7D-49BC-8A31-DC96DCA280DA

Q35234869-84D72A79-6B1E-4A44-AEA6-5557A6B73EFD

Q35234869-9E1675B5-218A-4C68-8ABD-CA10B2663723

Q35234869-B941C265-8E52-43D2-B2A5-F61464AAACFD

Q35234869-DE81387D-74B8-4E57-9267-344C15F7EEFE

Q35234869-F745C28A-4C21-4B77-8A19-56EC53393AEE

P2860

Q35234869-03D74091-34F7-4ACD-808B-4134B702FDB9

Q35234869-04EFE66F-FE1C-4C36-955D-9CD955AC2588

Q35234869-08A1AE3B-3FEF-4909-8D81-25E0211068B7

Q35234869-230AF6F5-DFEC-42C7-B335-CF651D1569B1

Q35234869-23E134FB-92A0-4F58-96EF-028324919755

Q35234869-2D4062D4-970A-4254-843C-29F6555F5C4D

Q35234869-34E7C091-1F3B-49D0-ACF9-BFB93424112D

Q35234869-3879F983-BC6F-41A4-91D4-C41B6982722D

Q35234869-3A39C928-0118-4427-8F9E-9FCB117A5221

Q35234869-3A6A72ED-7AD6-4E88-AF6C-C504E6374A6C

P2888

Q35234869-1FEF1450-EE65-4280-8512-B39F9F477955

P304

Q35234869-7D0E181F-041F-4F0B-A9A9-B2B1CED6ACF0

P31

Q35234869-AFFFED0F-DBEA-483F-9964-E7804E8A8F60

P356

Q35234869-092B80E6-D64D-4D58-A9A5-97071A7A668A

P433

Q35234869-8D14F03F-4311-47B4-8951-11177BA0628C

P478

Q35234869-19B997F0-F116-4EF4-98F5-26492ACF6EE2

P577

Q35234869-5AE83DA1-8FC8-48D9-8463-BDCA35532E33

P5875

Q35234869-4EEB2E70-F4D4-4D5F-9697-E1007F14A615

P698

Q35234869-21B5D958-19E1-4D0B-A7FD-7F558F364C21

P921

Q35234869-46440110-1FC6-41FA-AC4D-B1A4F4FDE35B

P932

Q35234869-82C9E861-D72D-442E-9E91-E51FFEF5892F

P356

S12975-011-0085-1

P1433

Translational stroke research

P1476

Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.

@en

P2093

Arthur A Vandenbark

http://www.w3.org/2001/XMLSchema#string

Halina Offner

http://www.w3.org/2001/XMLSchema#string

Julie Palmateer

http://www.w3.org/2001/XMLSchema#string

Kozaburo Akiyoshi

http://www.w3.org/2001/XMLSchema#string

Paco S Herson

http://www.w3.org/2001/XMLSchema#string

Patricia D Hurn

http://www.w3.org/2001/XMLSchema#string

Suzan Dziennis

http://www.w3.org/2001/XMLSchema#string

Xuefang Ren

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome

Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice.

Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice.

Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG

RTL therapy for multiple sclerosis: a Phase I clinical study.

MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis.

Ipsilesional motor deficits following stroke reflect hemispheric specializations for movement control.

Recombinant T cell receptor ligand treats experimental stroke.

Inflammation after stroke: mechanisms and therapeutic approaches.

P2888

s12975-011-0085-1

P304

404-410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12975-011-0085-1

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51683171

http://www.w3.org/2001/XMLSchema#string

P698

21961027

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

P932

3181103

http://www.w3.org/2001/XMLSchema#string